A PYMNTS Company

US/Germany: Bayer makes $1.1B birth control purchase

By  |  April 29, 2013

Pharmaceutical company Bayer, based in Germany, has reportedly agreed to pay $1.1 billion for California-based Conceptus, a manufacturer of an irreversible birth control method called Essure. According to Bayer’s CEO, the move was a “strategic” way to expand the company in the birth control market, as it already markets birth control pills. The parties expect to complete the transaction by mid-2013 while acknowledging that the deal is subject to antitrust regulators.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    Subscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Full Content: USA Today

    We’d love to be your preferred source for news.

    Please add us to your preferred sources list so our news, data and interviews show up in your feed. Thanks!

    Add as Preferred Source

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.